Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.72+0.06 (+3.61%)
Close on Nov 18, 2026Market cap $4.37MP/E –Yield –
Alaunos Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Alaunos Therapeutics's price to book ratio was 6.1× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 0.9× to 13.2×, with a median of 3.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.1× | +3.6 |
| 2025 | Dec 31, 2025 | 2.5× | +1.4 |
| 2024 | Dec 31, 2024 | 1.1× | −0.1 |
| 2023 | Dec 29, 2023 | 1.2× | −3.2 |
| 2022 | Dec 30, 2022 | 4.4× | +0.9 |
| 2021 | Dec 31, 2021 | 3.4× | −0.3 |
| 2020 | Dec 31, 2020 | 3.7× | −4.3 |
| 2019 | Dec 31, 2019 | 8.1× | −0.2 |
| 2016 | Jul 29, 2016 | 8.2× | −3.4 |
| 2015 | Dec 31, 2015 | 11.6× | −2.7 |
| 2014 | Dec 31, 2014 | 14.3× | −85.7 |
| 2013 | Dec 31, 2013 | 100.0× | +94.4 |
| 2012 | Dec 31, 2012 | 5.6× | +2.0 |
| 2011 | Dec 30, 2011 | 3.6× | −1.8 |
| 2010 | Dec 31, 2010 | 5.4× | – |
See a number that looks wrong?